Thyrocare Technologies Future Growth
Future criteria checks 4/6
Thyrocare Technologies is forecast to grow earnings and revenue by 23.5% and 12.9% per annum respectively. EPS is expected to grow by 23.8% per annum. Return on equity is forecast to be 17.6% in 3 years.
Key information
23.5%
Earnings growth rate
23.8%
EPS growth rate
| Healthcare earnings growth | 26.9% |
| Revenue growth rate | 12.9% |
| Future return on equity | 17.6% |
| Analyst coverage | Low |
| Last updated | 15 Apr 2024 |
Recent future growth updates
Revenue Miss: Thyrocare Technologies Limited Fell 10.0% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 04
Earnings Update: Thyrocare Technologies Limited (NSE:THYROCARE) Just Reported And Analysts Are Boosting Their Estimates
Nov 01Recent updates
Getting In Cheap On Thyrocare Technologies Limited (NSE:THYROCARE) Might Be Difficult
Feb 29Revenue Miss: Thyrocare Technologies Limited Fell 10.0% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 04Here's Why Thyrocare Technologies (NSE:THYROCARE) Can Manage Its Debt Responsibly
Dec 08Why Thyrocare Technologies' (NSE:THYROCARE) Shaky Earnings Are Just The Beginning Of Its Problems
Nov 08Thyrocare Technologies (NSE:THYROCARE) Knows How To Allocate Capital Effectively
Mar 23Thyrocare Technologies Limited (NSE:THYROCARE) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Mar 02Investors In Thyrocare Technologies Limited (NSE:THYROCARE) Should Consider This, First
Feb 01Investors Who Bought Thyrocare Technologies (NSE:THYROCARE) Shares A Year Ago Are Now Up 81%
Jan 12
The Chairman & MD of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Just Bought A Few More Shares
Dec 24Under The Bonnet, Thyrocare Technologies' (NSE:THYROCARE) Returns Look Impressive
Dec 17Thyrocare Technologies Limited's (NSE:THYROCARE) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Nov 30Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher
Nov 02Earnings Update: Thyrocare Technologies Limited (NSE:THYROCARE) Just Reported And Analysts Are Boosting Their Estimates
Nov 01How Does Thyrocare Technologies Limited (NSE:THYROCARE) Fare As A Dividend Stock?
Oct 28Insider Buying: The Thyrocare Technologies Limited (NSE:THYROCARE) Chairman Just Bought ₹20m Worth Of Shares
Oct 07The Thyrocare Technologies (NSE:THYROCARE) Share Price Has Gained 51% And Shareholders Are Hoping For More
Sep 29Will Thyrocare Technologies (NSE:THYROCARE) Repeat Its Return Growth Of The Past?
Sep 11Trade Alert: The Chairman Of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Has Just Spent ₹9.6m Buying A Few More Shares
Aug 22Thyrocare Technologies Limited's (NSE:THYROCARE) Price In Tune With Earnings
Aug 17Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher
Jul 30Investor Optimism Abounds Thyrocare Technologies Limited (NSE:THYROCARE) But Growth Is Lacking
Jul 28Should Weakness in Thyrocare Technologies Limited's (NSE:THYROCARE) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Jul 04Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2026 | 7,347 | 1,131 | N/A | N/A | 1 |
| 3/31/2025 | 6,338 | 906 | N/A | N/A | 1 |
| 3/31/2024 | 5,649 | 747 | N/A | N/A | 1 |
| 12/31/2023 | 5,535 | 655 | N/A | N/A | N/A |
| 9/30/2023 | 5,468 | 648 | 647 | 1,418 | N/A |
| 6/30/2023 | 5,338 | 599 | N/A | N/A | N/A |
| 3/31/2023 | 5,267 | 644 | 857 | 1,293 | N/A |
| 12/31/2022 | 5,214 | 731 | N/A | N/A | N/A |
| 9/30/2022 | 5,108 | 800 | 749 | 1,001 | N/A |
| 6/30/2022 | 5,520 | 1,423 | N/A | N/A | N/A |
| 3/31/2022 | 5,889 | 1,761 | 756 | 1,134 | N/A |
| 12/31/2021 | 6,051 | 1,924 | N/A | N/A | N/A |
| 9/30/2021 | 6,260 | 2,032 | 1,249 | 1,642 | N/A |
| 6/30/2021 | 6,030 | 1,685 | N/A | N/A | N/A |
| 3/31/2021 | 4,946 | 1,132 | 880 | 1,147 | N/A |
| 12/31/2020 | 4,503 | 741 | N/A | N/A | N/A |
| 9/30/2020 | 4,178 | 692 | 789 | 1,004 | N/A |
| 6/30/2020 | 3,797 | 612 | N/A | N/A | N/A |
| 3/31/2020 | 4,343 | 884 | 1,580 | 1,679 | N/A |
| 12/31/2019 | 4,384 | 1,063 | N/A | N/A | N/A |
| 9/30/2019 | 4,289 | 990 | 1,305 | 1,436 | N/A |
| 6/30/2019 | 4,165 | 892 | N/A | N/A | N/A |
| 3/31/2019 | 4,039 | 851 | 601 | 1,003 | N/A |
| 12/31/2018 | 3,946 | 939 | N/A | N/A | N/A |
| 9/30/2018 | 3,822 | 953 | N/A | N/A | N/A |
| 6/30/2018 | 3,663 | 947 | N/A | N/A | N/A |
| 3/31/2018 | 3,569 | 933 | 634 | 1,070 | N/A |
| 12/31/2017 | 3,493 | 1,117 | N/A | N/A | N/A |
| 9/30/2017 | 3,359 | 994 | N/A | N/A | N/A |
| 6/30/2017 | 3,258 | 759 | N/A | N/A | N/A |
| 3/31/2017 | 3,045 | 428 | N/A | 896 | N/A |
| 12/31/2016 | 2,843 | 659 | N/A | N/A | N/A |
| 9/30/2016 | 2,699 | 601 | N/A | N/A | N/A |
| 6/30/2016 | 2,535 | 564 | N/A | N/A | N/A |
| 3/31/2016 | 2,411 | 518 | N/A | 678 | N/A |
| 3/31/2015 | 1,835 | 452 | N/A | 345 | N/A |
| 3/31/2014 | 1,502 | 462 | N/A | 462 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: THYROCARE's forecast earnings growth (23.5% per year) is above the savings rate (6.7%).
Earnings vs Market: THYROCARE's earnings (23.5% per year) are forecast to grow faster than the Indian market (17.8% per year).
High Growth Earnings: THYROCARE's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: THYROCARE's revenue (12.9% per year) is forecast to grow faster than the Indian market (10.2% per year).
High Growth Revenue: THYROCARE's revenue (12.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: THYROCARE's Return on Equity is forecast to be low in 3 years time (17.6%).